155 related articles for article (PubMed ID: 15842128)
1. Commentary: A new approach to atherogenic dyslipidemia.
Reasner CA
Postgrad Med; 2005 Apr; 117(4):13-6. PubMed ID: 15842128
[No Abstract] [Full Text] [Related]
2. Antioxidants blunt high-density lipoprotein response to statin plus niacin therapy.
Kris-Etherton PM
Curr Atheroscler Rep; 2001 Nov; 3(6):435-6. PubMed ID: 11602062
[No Abstract] [Full Text] [Related]
3. The effects of simvastatin-niacin and antioxidant therapy on HDL.
Drown DJ
Prog Cardiovasc Nurs; 2002; 17(2):102-3. PubMed ID: 11986546
[No Abstract] [Full Text] [Related]
4. Niacin as a component of combination therapy for dyslipidemia.
Miller M
Mayo Clin Proc; 2003 Jun; 78(6):735-42. PubMed ID: 12934785
[TBL] [Abstract][Full Text] [Related]
5. Comparison of once-daily, niacin extended-release/lovastatin with standard doses of atorvastatin and simvastatin (the ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE]).
Bays HE; Dujovne CA; McGovern ME; White TE; Kashyap ML; Hutcheson AG; Crouse JR;
Am J Cardiol; 2003 Mar; 91(6):667-72. PubMed ID: 12633795
[TBL] [Abstract][Full Text] [Related]
6. How cost-effective is the treatment of dyslipidemia in patients with diabetes but without cardiovascular disease? A response to Grover et al.
Egede LE
Diabetes Care; 2001 Jul; 24(7):1306-7. PubMed ID: 11423528
[No Abstract] [Full Text] [Related]
7. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
Nesto RW
Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
[TBL] [Abstract][Full Text] [Related]
8. Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.
Isles CG; Paterson JR
QJM; 2000 Sep; 93(9):567-74. PubMed ID: 10984551
[TBL] [Abstract][Full Text] [Related]
9. Normocholesterolaemic dyslipidaemia: is there a role for fibrates?
Tallis GA
Med J Aust; 2001 Jun; 174(11):610; author reply 611. PubMed ID: 11453340
[No Abstract] [Full Text] [Related]
10. Non-adherence to lipid-lowering therapies: a need for more studies to evaluate reasons for medication non-adherence.
Wong MC; Wang HH; Liu KS
Int J Clin Pract; 2011 Dec; 65(12):1321-2. PubMed ID: 22093540
[No Abstract] [Full Text] [Related]
11. Advances in the understanding and management of dyslipidemia: using niacin-based therapies.
Ito MK
Am J Health Syst Pharm; 2003 Jul; 60(13 Suppl 2):S15-21; quiz S25. PubMed ID: 12901026
[TBL] [Abstract][Full Text] [Related]
12. The addition of niacin to statin therapy improves high-density lipoprotein cholesterol levels but not metrics of functionality.
Khera AV; Patel PJ; Reilly MP; Rader DJ
J Am Coll Cardiol; 2013 Nov; 62(20):1909-10. PubMed ID: 23933538
[No Abstract] [Full Text] [Related]
13. Trial clouds use of niacin with a statin.
Harv Heart Lett; 2011 Aug; 21(12):2. PubMed ID: 21991606
[No Abstract] [Full Text] [Related]
14. [Niacin--an additive therapeutic approach for optimizing lipid profile].
Wieneke H; Schmermund A; Erbel R
Med Klin (Munich); 2005 Apr; 100(4):186-92. PubMed ID: 15834527
[TBL] [Abstract][Full Text] [Related]
15. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome.
Grundy SM
Am J Cardiol; 1998 Feb; 81(4A):18B-25B. PubMed ID: 9526809
[TBL] [Abstract][Full Text] [Related]
16. What does the future hold for niacin as a treatment for hyperlipidaemia and cardiovascular disease?
Ahmed MH
J Cardiovasc Med (Hagerstown); 2010 Nov; 11(11):858-60. PubMed ID: 20686417
[TBL] [Abstract][Full Text] [Related]
17. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy for dyslipidemia: safety and regulatory considerations.
Davidson MH
Am J Cardiol; 2002 Nov; 90(10B):50K-60K. PubMed ID: 12467940
[TBL] [Abstract][Full Text] [Related]
19. Getting more people on statins.
Roberts WC
Am J Cardiol; 2002 Sep; 90(6):683-5. PubMed ID: 12231110
[No Abstract] [Full Text] [Related]
20. Use of combination therapy for dyslipidemia: a lipid clinic approach.
Brown AS
Am J Cardiol; 2002 Nov; 90(10B):44K-49K. PubMed ID: 12467939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
